We are currently re-vamping our web site in order to tell you about some new and exciting things about our company. To subscribe to our mailing list and be notified when we go live, fill out this form.
Our new site will be up and running shortly! If you'd like to know when we go live, sign up for our e-mail list
We’re pleased to announce that ImaginAb has concluded its Series A financing. You can read all about it here.
About ImaginAb
ImaginAb’s mission is to transform the clinical management of cancer and autoimmune diseases via targeted molecular imaging. We re-engineer therapeutic antibodies against biologically important targets into small proteins optimized for diagnostic imaging with Positron Emission Tomography (PET). We believe that in the era of targeted molecular therapy, there is a major unmet need for true companion in vivo diagnostics to help realize the promise of personalized medicine.
Join ImaginAb Newsletter
© Copyright 2012 ImaginAb All Rights Reserved.
Designed and Developed by
